Patents by Inventor Meiniang WANG

Meiniang WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOBODY FOR PCSK9 AND APPLICATION THEREOF
    Publication number: 20230091895
    Abstract: Disclosed is an antibody capable of specifically recognizing PCSK9 or an antigen-binding fragment thereof. The antibody comprises heavy chain variable region CDR1, CDR2, and CDR3 sequences shown in SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 or shown in amino acid sequences having at least 95% identity to SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3. The antibody can specifically bind to PCSK9 and inhibit the activity of PCSK9.
    Type: Application
    Filed: August 9, 2022
    Publication date: March 23, 2023
    Applicant: BGI SHENZHEN
    Inventors: Naibo Yang, Xiaoyan Gao, Xinyang Li, Xinhua Zhang, Meiniang Wang
  • Anti-BCMA single-chain antibody scFv and preparation method and application thereof
    Publication number: 20210246220
    Abstract: Provided are an anti-BCMA single-chain antibody scFv and a preparation method and application thereof. The preparation method is capable of artificially synthesizing a BCMA-targeted phage display library by combining site-directed mutagenesis and random mutagenesis technologies; and acquiring 3 new-type BCMA antigen-targeted scFv strains to serve as BCMA-targeted antibodies by combining a phage display technology.
    Type: Application
    Filed: October 10, 2018
    Publication date: August 12, 2021
    Inventors: Meiniang WANG, Bingjie OUYANG, Naibo YANG, Lin JIANG, Bingzhao REN, Yang LIU, Zhengqi ZHAO, Bo LI, Yong HOU, Fei WANG, Yuping GE, Xuan DONG